SCHEMBL1709735

SCHEMBL1709735

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNC(=O)OCC(C)C)n(C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.47
SCN1A P35498 2/20 0.36
SCN2A Q99250 2/20 0.36
SCN3A Q9NY46 2/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
GAA P10253 1/20 0.35
GLS O94925 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC22A1 O15245 1/20 0.32
CCR4 P51679 1/20 0.32
LMNA P02545 2/20 0.32
ALDH1A1 P00352 1/20 0.32
AGTR1 P30556 1/20 0.31
AGTR2 P50052 1/20 0.31
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709692 0.92 GHSR (0.48) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709694 0.91 GHSR (0.48) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL10121714 0.89 GHSR (0.47) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709729 0.88 GHSR (0.48) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709734 0.87 GHSR (0.49) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709679 0.87 GHSR (0.47) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL10121697 0.87 GHSR (0.47) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709575 0.86 HSD17B10 (0.40) GHSRHDAC1HDAC6SIRT2
SCHEMBL10121710 0.86 GHSR (0.48) GHSRSCN1ASCN2ASCN3AHDAC1
SCHEMBL1709700 0.86 GHSR (0.46) GHSRSCN1ASCN2ASCN3AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885SCN1A 306/4885SCN2A 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.